Update on clinical and immunological features of eosinophilic gastrointestinal diseases

Joanne C. Masterson, Glenn T. Furuta, James J. Lee

Research output: Contribution to journalArticle

29 Citations (Scopus)

Abstract

Purpose of review: Eosinophilic gastrointestinal diseases (EGIDs) are an increasingly common heterogeneous group of intestinal diseases. The purpose of this review is to present the latest developments in the care of patients with EGIDs and to summarize a growing literature defining the clinical features and mechanistic elements of eosinophils and their complex relationships with the gastrointestinal tract. Recent findings: Recent studies continue to define what constitutes 'normal' and 'abnormal' numbers of eosinophils in the different sections of the gastrointestinal tract. Symptom complexes of EGIDs appear to be related primarily to the mucosal, as opposed to the muscular or serosal, forms of EGIDs. Dissection of the mucosal microenvironment is uncovering a complex array of cells, other than eosinophils, that likely contribute to the inflammatory response associated with EGIDs. Mechanistic studies have identified genetic perturbations (eotaxin-3, thymic stromal lymphopoietin, IL-13, and filaggrin) that may also contribute to the development of the most often encountered and well studied EGID, eosinophilic esophagitis. Summary: Clinicians should remain aware of EGIDs as a diagnostic possibility for patients with common gastrointestinal symptoms. Additional research is needed to determine mechanistic processes leading to dysfunction associated with eosinophilic gastrointestinal inflammation.

Original languageEnglish (US)
Pages (from-to)515-522
Number of pages8
JournalCurrent Opinion in Gastroenterology
Volume27
Issue number6
DOIs
StatePublished - Oct 2011

Fingerprint

Gastrointestinal Diseases
Eosinophils
Gastrointestinal Tract
Eosinophilic Esophagitis
Intestinal Diseases
Interleukin-13
Dissection
Patient Care
Inflammation
Research

Keywords

  • eosinophilic esophagitis
  • eotaxin
  • filaggrin
  • mucosa
  • thymic stromal lymphopoetin

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Update on clinical and immunological features of eosinophilic gastrointestinal diseases. / Masterson, Joanne C.; Furuta, Glenn T.; Lee, James J.

In: Current Opinion in Gastroenterology, Vol. 27, No. 6, 10.2011, p. 515-522.

Research output: Contribution to journalArticle

Masterson, Joanne C. ; Furuta, Glenn T. ; Lee, James J. / Update on clinical and immunological features of eosinophilic gastrointestinal diseases. In: Current Opinion in Gastroenterology. 2011 ; Vol. 27, No. 6. pp. 515-522.
@article{8f32a5f737564354b0951257baf7af40,
title = "Update on clinical and immunological features of eosinophilic gastrointestinal diseases",
abstract = "Purpose of review: Eosinophilic gastrointestinal diseases (EGIDs) are an increasingly common heterogeneous group of intestinal diseases. The purpose of this review is to present the latest developments in the care of patients with EGIDs and to summarize a growing literature defining the clinical features and mechanistic elements of eosinophils and their complex relationships with the gastrointestinal tract. Recent findings: Recent studies continue to define what constitutes 'normal' and 'abnormal' numbers of eosinophils in the different sections of the gastrointestinal tract. Symptom complexes of EGIDs appear to be related primarily to the mucosal, as opposed to the muscular or serosal, forms of EGIDs. Dissection of the mucosal microenvironment is uncovering a complex array of cells, other than eosinophils, that likely contribute to the inflammatory response associated with EGIDs. Mechanistic studies have identified genetic perturbations (eotaxin-3, thymic stromal lymphopoietin, IL-13, and filaggrin) that may also contribute to the development of the most often encountered and well studied EGID, eosinophilic esophagitis. Summary: Clinicians should remain aware of EGIDs as a diagnostic possibility for patients with common gastrointestinal symptoms. Additional research is needed to determine mechanistic processes leading to dysfunction associated with eosinophilic gastrointestinal inflammation.",
keywords = "eosinophilic esophagitis, eotaxin, filaggrin, mucosa, thymic stromal lymphopoetin",
author = "Masterson, {Joanne C.} and Furuta, {Glenn T.} and Lee, {James J.}",
year = "2011",
month = "10",
doi = "10.1097/MOG.0b013e32834b314c",
language = "English (US)",
volume = "27",
pages = "515--522",
journal = "Current Opinion in Gastroenterology",
issn = "0267-1379",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

TY - JOUR

T1 - Update on clinical and immunological features of eosinophilic gastrointestinal diseases

AU - Masterson, Joanne C.

AU - Furuta, Glenn T.

AU - Lee, James J.

PY - 2011/10

Y1 - 2011/10

N2 - Purpose of review: Eosinophilic gastrointestinal diseases (EGIDs) are an increasingly common heterogeneous group of intestinal diseases. The purpose of this review is to present the latest developments in the care of patients with EGIDs and to summarize a growing literature defining the clinical features and mechanistic elements of eosinophils and their complex relationships with the gastrointestinal tract. Recent findings: Recent studies continue to define what constitutes 'normal' and 'abnormal' numbers of eosinophils in the different sections of the gastrointestinal tract. Symptom complexes of EGIDs appear to be related primarily to the mucosal, as opposed to the muscular or serosal, forms of EGIDs. Dissection of the mucosal microenvironment is uncovering a complex array of cells, other than eosinophils, that likely contribute to the inflammatory response associated with EGIDs. Mechanistic studies have identified genetic perturbations (eotaxin-3, thymic stromal lymphopoietin, IL-13, and filaggrin) that may also contribute to the development of the most often encountered and well studied EGID, eosinophilic esophagitis. Summary: Clinicians should remain aware of EGIDs as a diagnostic possibility for patients with common gastrointestinal symptoms. Additional research is needed to determine mechanistic processes leading to dysfunction associated with eosinophilic gastrointestinal inflammation.

AB - Purpose of review: Eosinophilic gastrointestinal diseases (EGIDs) are an increasingly common heterogeneous group of intestinal diseases. The purpose of this review is to present the latest developments in the care of patients with EGIDs and to summarize a growing literature defining the clinical features and mechanistic elements of eosinophils and their complex relationships with the gastrointestinal tract. Recent findings: Recent studies continue to define what constitutes 'normal' and 'abnormal' numbers of eosinophils in the different sections of the gastrointestinal tract. Symptom complexes of EGIDs appear to be related primarily to the mucosal, as opposed to the muscular or serosal, forms of EGIDs. Dissection of the mucosal microenvironment is uncovering a complex array of cells, other than eosinophils, that likely contribute to the inflammatory response associated with EGIDs. Mechanistic studies have identified genetic perturbations (eotaxin-3, thymic stromal lymphopoietin, IL-13, and filaggrin) that may also contribute to the development of the most often encountered and well studied EGID, eosinophilic esophagitis. Summary: Clinicians should remain aware of EGIDs as a diagnostic possibility for patients with common gastrointestinal symptoms. Additional research is needed to determine mechanistic processes leading to dysfunction associated with eosinophilic gastrointestinal inflammation.

KW - eosinophilic esophagitis

KW - eotaxin

KW - filaggrin

KW - mucosa

KW - thymic stromal lymphopoetin

UR - http://www.scopus.com/inward/record.url?scp=80054681179&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80054681179&partnerID=8YFLogxK

U2 - 10.1097/MOG.0b013e32834b314c

DO - 10.1097/MOG.0b013e32834b314c

M3 - Article

C2 - 21897226

AN - SCOPUS:80054681179

VL - 27

SP - 515

EP - 522

JO - Current Opinion in Gastroenterology

JF - Current Opinion in Gastroenterology

SN - 0267-1379

IS - 6

ER -